News & Updates

In the treatment of patients with hypercholesterolaemia, the fixed-dose combination of pitavastatin plus ezetimibe, 1PC111, affords better low-density lipoprotein cholesterol (LDL-C)-lowering effect than either pitavastatin or ezetimibe alone, according to the results of a phase III trial.

Neither protein feeding nor physical activity interventions compromise the removal of uraemic toxins in end-stage renal disease patients on haemodialysis, reports a new study.

HCPs are advised to avoid using the word fat to describe a person with obesity, says an expert. 

Elevated endogenous testosterone levels do not necessarily translate to increased adverse events, as shown in a study.

Adrenal fatigue (AF) cases are seeing an uptick in preponderance, but it is not an accepted medical diagnosis, says a prominent expert.

With the increase in obese and overweight patients, physicians may need to have a high degree of suspicion for obstructive sleep apnoea (OSA), says a prominent respirologist. 

Gender dysphoria (GD) appears to be more common than previously estimated by clinic-based studies, according to the results of a population-based internet survey in Japan. In addition, GD more frequently correlates with age than with gender.